How to Prescribe Drugs With an Identified Proarrhythmic Liability.

Area of Science:

• Clinical Pharmacology
• Cardiology
• Pharmacology

Background:

• Drug-induced proarrhythmia is a significant concern, potentially leading to fatal arrhythmias like torsades de pointes (TdP).
• Various drug classes can prolong cardiac repolarization, increasing TdP risk.
• Identifying susceptible patients and understanding drug liability are essential for clinical practice.

Purpose of the Study:

• To educate medical students and residents on drug-induced proarrhythmia and torsades de pointes (TdP).
• To explain the mechanism of action for drugs prolonging repolarization.
• To guide prescribers in assessing patient risk and managing potential TdP events.

Main Methods:

• Review of pharmacological mechanisms of drug-induced proarrhythmia.
• Analysis of drug prescribing information for proarrhythmic liability.
• Description of patient clinical characteristics associated with TdP susceptibility.
• Outline of interventions for managing TdP.
• Inclusion of clinical vignettes for practical illustration.

Main Results:

• Drugs prolonging the cardiac repolarization period are a common cause of TdP.
• Prescribing information often details proarrhythmic risks.
• Certain patient factors increase susceptibility to TdP.
• Dose adjustments and monitoring can mitigate risks.
• Prompt intervention is necessary if TdP occurs.

Conclusions:

• Prescribers must understand drug benefit-risk profiles and patient factors to prevent TdP.
• Awareness of drug-induced proarrhythmia mechanisms and clinical manifestations is vital.
• Effective management strategies exist for TdP, emphasizing risk assessment and monitoring.